Literature DB >> 24184423

Effects of azole treatments on the physical properties of Candida albicans plasma membrane: a spin probe EPR study.

Cristina Sgherri1, Amalia Porta, Sabrina Castellano, Calogero Pinzino, Mike F Quartacci, Lucia Calucci.   

Abstract

EPR spectroscopy was applied to investigate the effects of the treatment of Candida albicans cells with fluconazole (FLC) and two newly synthesized azoles (CPA18 and CPA109), in a concentration not altering yeast morphology, on the lipid organization and dynamics of the plasma membrane. Measurements were performed in the temperature range between 0°C and 40°C using 5-doxyl- (5-DSA) and 16-doxyl- (16-DSA) stearic acids as spin probes. 5-DSA spectra were typical of lipids in a highly ordered environment, whereas 16-DSA spectra consisted of two comparable components, one corresponding to a fluid bulk lipid domain in the membrane and the other to highly ordered and motionally restricted lipids interacting with integral membrane proteins. A line shape analysis allowed the relative proportion and the orientational order and dynamic parameters of the spin probes in the different environments to be determined. Smaller order parameters, corresponding to a looser lipid packing, were found for the treated samples with respect to the control one in the region close to the membrane surface probed by 5-DSA. On the other hand, data on 16-DSA indicated that azole treatments hamper the formation of ordered lipid domains hosting integral proteins and/or lead to a decrease in integral protein content in the membrane. The observed effects are mainly ascribable to the inhibition of ergosterol biosynthesis by the antifungal agents, although a direct interaction of the CPA compounds with the membrane bilayer in the region close to the lipid polar head groups cannot be excluded.
© 2013.

Entities:  

Keywords:  1-(1-(biphenyl-4-yl)-3-(4-fluorophenyl)propan-2-yl)-1H-imidazole; 1-(1-(biphenyl-4-yl)-3-(5-chlorothiophen-2-yl)propan-2-yl)-1H-imidazole; 16-DSA; 16-doxylstearic acid; 5-DSA; 5-doxylstearic acid; Antifungal azole; CPA109; CPA18; Candida albicans; Doxyl-stearic acid; EPR; Electron Paramagnetic Resonance; FLC; FS; Fluconazole; MOMD; Membrane fluidity; PA; PE; PG; PI; PL; PS; fluconazole; free sterols; microscopically ordered macroscopically disordered; phosphatidic acid; phosphatidylethanolamine; phosphatidylglycerol; phosphatidylinositol; phosphatidylserine; phospholipid

Mesh:

Substances:

Year:  2013        PMID: 24184423     DOI: 10.1016/j.bbamem.2013.10.015

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  5 in total

Review 1.  The synthesis, regulation, and functions of sterols in Candida albicans: Well-known but still lots to learn.

Authors:  Quan-Zhen Lv; Lan Yan; Yuan-Ying Jiang
Journal:  Virulence       Date:  2016-05-24       Impact factor: 5.882

Review 2.  What 'Omics can tell us about antifungal adaptation.

Authors:  Gabriela Fior Ribeiro; Eszter Denes; Helen Heaney; Delma S Childers
Journal:  FEMS Yeast Res       Date:  2022-01-11       Impact factor: 2.923

3.  Antimicrobial and Antibiofilm Activity of Chitosan on the Oral Pathogen Candida albicans.

Authors:  Eduardo Costa; Sara Silva; Freni Tavaria; Manuela Pintado
Journal:  Pathogens       Date:  2014-12-11

4.  Synergistic Interactions of Eugenol-tosylate and Its Congeners with Fluconazole against Candida albicans.

Authors:  Aijaz Ahmad; Mohmmad Younus Wani; Amber Khan; Nikhat Manzoor; Julitha Molepo
Journal:  PLoS One       Date:  2015-12-22       Impact factor: 3.240

5.  Characterization of the Candida glabrata Transcription Factor CgMar1: Role in Azole Susceptibility.

Authors:  Pedro Pais; Mónica Galocha; Raquel Califórnia; Romeu Viana; Mihaela Ola; Michiyo Okamoto; Hiroji Chibana; Geraldine Butler; Miguel C Teixeira
Journal:  J Fungi (Basel)       Date:  2022-01-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.